Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism.

Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism.

High-resolution capacitance measurements were used to explore the effects of the gut hormones GLP-I(7-36) amide [glucagon-like peptide I(7-36) amide] and GIP (glucose-dependent insulinotropic polypeptide) on Ca2+-dependent exocytosis in glucagon-secreting rat pancreatic alpha-cells. Both peptides pr...

Bibliografske podrobnosti
Main Authors:	Ding, W, Renström, E, Rorsman, P, Buschard, K, Gromada, J
Format:	Journal article
Jezik:	English
Izdano:	1997

Podobne knjige/članki

Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion in humans: Characteristics and regulation
od: Wathik Alsalim, et al.
Izdano: (2023-03-01)

Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists
od: Dilek Tüzün
Izdano: (2022-06-01)

Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels.
od: Gromada, J, et al.
Izdano: (1997)

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
od: Agnieszka Jakubowska, et al.
Izdano: (2024-02-01)

Adrenaline stimulates secretion in rat pancreatic alpha-cells by PKA-dependent acceleration of Ca2+ influx through 1-type Ca2+- channels
od: Gromada, J, et al.
Izdano: (1996)

Regulation of glucose and energy metabolism through actions of glucagon‐like peptide‐1 and glucose‐dependent insulinotropic polypeptide
od: Yasuo Zenimaru, et al.
Izdano: (2024-12-01)

Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
od: Alexander C. Martins, et al.
Izdano: (2024-04-01)

New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
od: Gromada, J, et al.
Izdano: (2004)

Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
od: Tomislav Bulum
Izdano: (2022-10-01)

Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells.
od: Wendt, A, et al.
Izdano: (2004)

Glucose-dependent insulinotropic polypeptide (GIP)
od: Timo D. Müller, et al.
Izdano: (2025-05-01)

Emetic Response to T-2 Toxin Correspond to Secretion of Glucagon-like Peptide-<sub>17</sub><sub>–36</sub> Amide and Glucose-Dependent Insulinotropic Polypeptide
od: Jie Zhang, et al.
Izdano: (2022-06-01)

Hepatic and Extrahepatic Insulin Clearance in Mice with Double Deletion of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Receptors
od: Micaela Morettini, et al.
Izdano: (2021-08-01)

Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors.
od: Ma, X, et al.
Izdano: (2005)

Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.
od: Høy, M, et al.
Izdano: (2003)

Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes
od: Eiichi Araki, et al.
Izdano: (2022-12-01)

Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
od: Gromada, J, et al.
Izdano: (1997)

Somatostatin but not insulin is an important paracrine regulator of glucagon secretion in rat A-cells
od: Renstrom, E, et al.
Izdano: (1997)

Gastric inhibitory polypeptide/glucose‐dependent insulinotropic polypeptide signaling in adipose tissue
od: Shunsuke Yamane, et al.
Izdano: (2019-01-01)

Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
od: Gromada, J, et al.
Izdano: (2004)

Does the K-ATP channel participate in the regulation of glucagon secretion?
od: Bokvist, K, et al.
Izdano: (1999)

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
od: Gromada, J, et al.
Izdano: (1998)

Roles of glucose‐dependent insulinotropic polypeptide in diet‐induced obesity
od: Yusuke Seino, et al.
Izdano: (2022-07-01)

Expression of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in the rat submandibular gland is influenced by pre- and post-natal high-fat diet exposure
od: Pornchanok Sangsuriyothai, et al.
Izdano: (2024-03-01)

Differential effects of glucose‐dependent insulinotropic polypeptide receptor/glucagon‐like peptide‐1 receptor heteromerization on cell signaling when expressed in HEK‐293 cells
od: Bashaier Al‐Zaid, et al.
Izdano: (2022-10-01)

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
od: Enrique Z. Fisman, et al.
Izdano: (2021-11-01)

Serum Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the Risk of Gestational Diabetes: A Prospective Case-Control Study
od: Maryam Mosavat, et al.
Izdano: (2020-01-01)

Glucose-dependent insulinotropic polypeptide - a new link in the development of obesity
od: Ekaterina Alekseevna Shestakova, et al.
Izdano: (2015-04-01)

Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms.
od: Gromada, J, et al.
Izdano: (1996)

Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor
od: Fenghui Zhao, et al.
Izdano: (2021-07-01)

The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury
od: Florian Kahles, et al.
Izdano: (2022-02-01)

Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor
od: Xiaoshan Min, et al.
Izdano: (2020-01-01)

Glucose-dependent insulinotropic polypeptide and tissue inflammation: Implications for atherogenic cardiovascular disease
od: Xiaoming He
Izdano: (2022-01-01)

Glucose stimulates the entry of Ca2+ into the insulin-producing beta cells but not into the glucagon-producing alpha 2 cells.
od: Wesslén, N, et al.
Izdano: (1987)

Establishment of novel specific assay for short‐form glucose‐dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects
od: Yasutaka Takeda, et al.
Izdano: (2020-06-01)

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease—Current Evidence
od: Emir M. Muzurović MD, MM, et al.
Izdano: (2022-12-01)

Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
od: Isabella Zaffina, et al.
Izdano: (2023-02-01)

Molecular mechanism underlying glucagon-like peptide 1 induced calcium mobilization from internal stores in insulin-secreting beta TC3 cells.
od: Gromada, J, et al.
Izdano: (1996)

Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
od: Gromada, J, et al.
Izdano: (1995)

Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
od: Satoko Shimazu-Kuwahara, et al.
Izdano: (2017-03-01)